Add to Favourites
To login click here
Insilico Medicine founder and co-CEO, Alex Zhavoronkov, will be attending various events to discuss the use of AI and robotics in bioscience innovation. These events include London Tech Week 2024 and Founders Forum Global & Founders Longevity Forum. The discussions will focus on the impact of AI on drug discovery, commercialization, and licensing models.